Cargando…

mHealth-Assisted Detection of Precursors to Relapse in Schizophrenia

Theoretical views and a growing body of empirical evidence suggest that psychiatric relapses in schizophrenia-spectrum disorders (SSDs) have measurable warning signs. However, because they are time- and resource-intensive, existing assessment approaches are not well-suited to detect these warning si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buck, Benjamin, Hallgren, Kevin A., Campbell, Andrew T., Choudhury, Tanzeem, Kane, John M., Ben-Zeev, Dror
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202824/ https://www.ncbi.nlm.nih.gov/pubmed/34135781 http://dx.doi.org/10.3389/fpsyt.2021.642200

Ejemplares similares

Assessing the relationship between routine and schizophrenia symptoms with passively sensed measures of behavioral stability
por: He-Yueya, Joy, et al.
Publicado: (2020)

Predicting Early Warning Signs of Psychotic Relapse From Passive Sensing Data: An Approach Using Encoder-Decoder Neural Networks
por: Adler, Daniel A, et al.
Publicado: (2020)

Analyzing mHealth Engagement: Joint Models for Intensively Collected User Engagement Data
por: Scherer, Emily A, et al.
Publicado: (2017)

mHealth for Young Adults with Early Psychosis: User Preferences and Their Relationship to Attitudes About Treatment-Seeking
por: Buck, Benjamin, et al.
Publicado: (2021)

FOCUS mHealth Intervention for Veterans With Serious Mental Illness in an Outpatient Department of Veterans Affairs Setting: Feasibility, Acceptability, and Usability Study
por: Buck, Benjamin, et al.
Publicado: (2022)

Using behavioral rhythms and multi-task learning to predict fine-grained symptoms of schizophrenia
por: Tseng, Vincent W.-S., et al.
Publicado: (2020)

Predicting Psychotic Relapse in Schizophrenia With Mobile Sensor Data: Routine Cluster Analysis
por: Zhou, Joanne, et al.
Publicado: (2022)

WeChat-based mHealth intention and preferences among people living with schizophrenia
por: Xiao, Shuiyuan, et al.
Publicado: (2020)

mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge
por: Ben-Zeev, Dror, et al.
Publicado: (2016)

mHealth App for Cannabis Users: Satisfaction and Perceived Usefulness
por: Monney, Grégoire, et al.
Publicado: (2015)

Development and Clinical Evaluation of an mHealth Application for Stress Management
por: Winslow, Brent D., et al.
Publicado: (2016)

Editorial: mHealth: Self-Management and Complementary Psychiatric Treatment
por: Achtyes, Eric D., et al.
Publicado: (2021)

A technology-assisted life of recovery from psychosis
por: Ben-Zeev, Dror, et al.
Publicado: (2019)

Identifying Modifiable Risk Factors for Relapse in Patients With Schizophrenia in China
por: Mi, Wei-Feng, et al.
Publicado: (2020)

Increased brain gyrification and subsequent relapse in patients with first-episode schizophrenia
por: Sasabayashi, Daiki, et al.
Publicado: (2022)

Transdiagnostic Mobile Health: Smartphone Intervention Reduces Depressive Symptoms in People With Mood and Psychotic Disorders
por: Ben-Zeev, Dror, et al.
Publicado: (2019)

Utilizing Instagram Data to Identify Usage Patterns Associated With Schizophrenia Spectrum Disorders
por: Hänsel, Katrin, et al.
Publicado: (2021)

A Patient With Schizophrenia in Remission Relapses Following COVID-19: A Case Report
por: Shaaban, Saeed S, et al.
Publicado: (2022)

Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States
por: Lin, Dee, et al.
Publicado: (2021)

mHealth Solutions for Mental Health Screening and Diagnosis: A Review of App User Perspectives Using Sentiment and Thematic Analysis
por: Funnell, Erin Lucy, et al.
Publicado: (2022)

Developing a mHealth Routine Outcome Monitoring and Feedback App (“SMART Track”) to Support Self-Management of Addictive Behaviours
por: Beck, Alison K., et al.
Publicado: (2021)

Maternal Immune Activation and Schizophrenia–Evidence for an Immune Priming Disorder
por: Choudhury, Zahra, et al.
Publicado: (2021)

A randomized controlled trial of an mHealth application with nursing interaction to promote quality of life among community-dwelling older adults
por: Wong, Arkers Kwan Ching, et al.
Publicado: (2022)

Relationship between social support and schizophrenia relapse among patients with schizophrenia on follow-up at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia: A case-control study
por: Samuel, Tinbete, et al.
Publicado: (2022)

Acute paranoid schizophrenia relapsed inpatients present summer/ winter but not day/night changes in serum S100B concentrations
por: Armando L., Morera-Fumero, et al.
Publicado: (2021)

Case report: Successful administration of cariprazine in a young, severely ill patient with recurrent relapses of schizophrenia and persistent negative symptoms
por: Vrublevska, Jelena
Publicado: (2023)

Computer-Assisted Cognitive Remediation in Schizophrenia: Efficacy of an Individualized vs. Generic Exercise Plan
por: Bossert, Magdalena, et al.
Publicado: (2020)

Dog-assisted interventions for adults diagnosed with schizophrenia and related disorders: a systematic review
por: Tyssedal, Malene Kalsnes, et al.
Publicado: (2023)

Effectiveness of Nature- and Animal Assisted Mindfulness for Relapse Prevention in Depressed Patients With a History of Childhood Maltreatment
por: Schramm, Elisabeth, et al.
Publicado: (2022)

Leptin Methylation and mRNA Expression Associated With Psychopathology in Schizophrenia Inpatients
por: Song, Jiaqi, et al.
Publicado: (2022)

Altered Expression of Glucocorticoid Receptor and Neuron-Specific Enolase mRNA in Peripheral Blood in First-Episode Schizophrenia and Chronic Schizophrenia
por: Liu, Yong, et al.
Publicado: (2020)

COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

Animal-Assisted Therapy in Middle-Aged and Older Patients With Schizophrenia: A Randomized Controlled Trial
por: Chen, Tzu-Ting, et al.
Publicado: (2021)

Is befriending a valuable intervention in schizophrenia? A scoping review
por: Farcas, Adriana, et al.
Publicado: (2023)

O9.7. TECHNOLOGY ASSISTED RELAPSE PREVENTION PROGRAM REDUCES HOSPITALIZATION IN SCHIZOPHRENIA PATIENTS AT HIGH RISK FOR RELAPSE
por: Schooler, Nina, et al.
Publicado: (2020)

Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia
por: Nicoletti, Ferdinando, et al.
Publicado: (2019)

Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review
por: Coles, Alexandria S., et al.
Publicado: (2021)

Expanding the Reach of Research: Quantitative Evaluation of a Web-Based Approach for Remote Recruitment of People Who Hear Voices
por: Buck, Benjamin, et al.
Publicado: (2021)

An mHealth intervention to prevent postnatal smoking relapse: The RESPREMO study protocol
por: Dascal, Marina, et al.
Publicado: (2020)

Regressive Autism Spectrum Disorder: High Levels of Total Secreted Amyloid Precursor Protein and Secreted Amyloid Precursor Protein-α in Plasma
por: Li, Xiaoli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lj7rteo0jde7n50q32gkemrklq